Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
116.55
+4.99 (4.47%)
Nov 21, 2024, 4:00 PM EST - Market closed
Ligand Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 45.24 | 52.15 | -33.36 | 57.14 | -2.99 | 629.3 | Upgrade
|
Depreciation & Amortization | 34.65 | 35.64 | 51.37 | 50.95 | 27.97 | 43.73 | Upgrade
|
Other Amortization | 2.45 | 1.98 | 6.26 | 21.53 | 24.69 | 29.99 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -2.12 | - | - | -17.11 | -812.8 | Upgrade
|
Asset Writedown & Restructuring Costs | 26.49 | 0.92 | - | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | -90.27 | -47.68 | -28.52 | 4.11 | 18.41 | -11.32 | Upgrade
|
Loss (Gain) on Equity Investments | 13.41 | 1.83 | - | - | - | - | Upgrade
|
Stock-Based Compensation | 39.29 | 25.74 | 60.29 | 38.78 | 30.73 | 24.52 | Upgrade
|
Other Operating Activities | 13.61 | 15.52 | 16.15 | -36.71 | -15.43 | 71.3 | Upgrade
|
Change in Accounts Receivable | 2.04 | -2.6 | 55.32 | -28.62 | -26.06 | 25.46 | Upgrade
|
Change in Inventory | 7.76 | -10.87 | 12.06 | -0.43 | -17.8 | -2.06 | Upgrade
|
Change in Accounts Payable | 5.37 | -4.7 | -3.34 | 2.81 | -1.25 | -6.66 | Upgrade
|
Change in Unearned Revenue | -0.98 | 0.42 | -6.28 | -17.87 | 29.24 | -1.15 | Upgrade
|
Change in Income Taxes | -8.21 | -1.78 | 1.58 | -3.98 | 9.14 | -11.22 | Upgrade
|
Change in Other Net Operating Assets | -14.23 | -14.87 | 6.34 | -8.93 | -4.95 | -8.43 | Upgrade
|
Operating Cash Flow | 76.64 | 49.58 | 137.85 | 78.8 | 54.59 | -29.34 | Upgrade
|
Operating Cash Flow Growth | -19.31% | -64.04% | 74.94% | 44.36% | - | - | Upgrade
|
Capital Expenditures | -1.53 | -3.52 | -17.92 | -8.76 | -4.46 | -2.55 | Upgrade
|
Cash Acquisitions | - | -10.41 | - | - | -404.88 | -11.84 | Upgrade
|
Divestitures | - | - | - | - | 22.06 | - | Upgrade
|
Sale (Purchase) of Intangibles | -49.91 | -49.91 | 0.09 | 0.49 | 1.36 | 812.8 | Upgrade
|
Investment in Securities | -48.11 | 52.15 | 182.42 | 40.01 | 615.67 | -326.82 | Upgrade
|
Other Investing Activities | -15.78 | - | -0.96 | -1.22 | 1.9 | -4.67 | Upgrade
|
Investing Cash Flow | -115.33 | -11.68 | 163.62 | 30.52 | 231.65 | 466.92 | Upgrade
|
Long-Term Debt Repaid | - | -76.9 | -261 | -164.95 | -231.76 | -27.32 | Upgrade
|
Net Debt Issued (Repaid) | -0.02 | -76.9 | -261 | -164.95 | -231.76 | -27.32 | Upgrade
|
Issuance of Common Stock | 52.78 | 22.45 | 3.23 | 33.76 | 3.02 | 3 | Upgrade
|
Repurchase of Common Stock | -3.46 | -4.55 | -8.24 | -6.02 | -79.48 | -457.47 | Upgrade
|
Other Financing Activities | 32.77 | -0.95 | -9.98 | -0.56 | -2.33 | -3.38 | Upgrade
|
Financing Cash Flow | 82.07 | -59.95 | -275.99 | -137.76 | -310.55 | -485.17 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.38 | - | - | - | - | 0.08 | Upgrade
|
Net Cash Flow | 43.76 | -22.05 | 25.48 | -28.44 | -24.31 | -47.51 | Upgrade
|
Free Cash Flow | 75.12 | 46.06 | 119.93 | 70.04 | 50.13 | -31.89 | Upgrade
|
Free Cash Flow Growth | -16.31% | -61.60% | 71.23% | 39.72% | - | - | Upgrade
|
Free Cash Flow Margin | 49.28% | 35.07% | 61.11% | 29.00% | 30.65% | -26.51% | Upgrade
|
Free Cash Flow Per Share | 4.09 | 2.59 | 7.11 | 4.06 | 2.98 | -1.61 | Upgrade
|
Cash Interest Paid | 0.26 | 0.29 | 1.43 | 3.03 | 4.46 | 5.83 | Upgrade
|
Cash Income Tax Paid | 26.11 | 8.77 | 11.64 | 3.72 | 2.13 | 103.82 | Upgrade
|
Levered Free Cash Flow | 16.96 | -4.76 | 144.51 | 37.03 | 123.51 | 885.43 | Upgrade
|
Unlevered Free Cash Flow | 17.99 | -4.59 | 144.9 | 32.6 | 117.57 | 877.78 | Upgrade
|
Change in Net Working Capital | 17.8 | 20.42 | -53.06 | 85.65 | -40.29 | -2.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.